DexCom (NASDAQ:DXCM) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

DexCom (NASDAQ:DXCM – Get Rating) released its earnings results on Thursday. The medical device company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.15 by $0.02, Briefing.com reports. DexCom had a net margin of 9.68% and a return on equity of 18.65%. The business had revenue of $7.45 billion during the quarter, […]

Related Keywords

Manhattan ,New York ,United States ,Steven Robert Pacelli ,Raymond James ,Stifel Nicolaus ,Jacob Steven Leach ,Money Concepts Capital Corp ,Morgan Stanley ,Kb Financial Partners ,Barclays ,Atlas Capital Advisors ,First Manhattan Co ,Dexcom Inc ,Group Wealth Management ,Get Rating ,Com Stock Down ,Director Steven Robert Pacelli ,Steven Leach ,Capital Advisors ,Wealth Management ,Concepts Capital Corp ,Dexcom Daily ,Dexcom ,Nasdaq Dxcm ,Dxcm ,Medical ,25213110 ,Earnings ,